Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001178913-26-001228
Filing Date
2026-03-18
Accepted
2026-03-18 12:18:21
Documents
2
Period of Report
2026-03-18

Document Format Files

Seq Description Document Type Size
1 FORM 3 zk2634742.html 3  
1 FORM 3 zk2634742.xml 3 8092
2 EXHIBIT 24 exhibit_24.htm EX-24 8541
  Complete submission text file 0001178913-26-001228.txt   18271
Mailing Address 7 GOLDA MEIR ST. WEIZMANN SCIENCE PARK NESS ZIONA L3 Israel 7403648
Business Address 7 GOLDA MEIR ST. WEIZMANN SCIENCE PARK NESS ZIONA L3 Israel 7403648 97289313433
Sol-Gel Technologies Ltd. (Issuer) CIK: 0001684693 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address SOL-GEL TECHNOLOGIES LTD GOLDA MEIR 7 NESS-ZIONA L3 7403650
Business Address
Levy-Hacham Ofra (Reporting) CIK: 0001983525 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38367 | Film No.: 26767254